Purpose: To evaluate and compare the glaucoma discrimination ability of macula, macular ganglion cell complex (mGCC), and peripapillary nerve fiber layer (ppNFL) thickness in Chinese patients using Fourier-domain optical coherence tomography (FD-OCT).
Methods: A total of 64 normal subjects (N), 47 glaucoma suspects (GS), and 48 glaucoma patients (G) were enrolled in the study. The thickness of mGCC, ppNFL, and total macula were measured using RTVue-100 FD-OCT (software version: 4.0.7.5; Optovue). The GCC and ONH protocols were used for obtaining images in all subjects. For each binocular subject, one eye was chosen randomly for analysis.
Results: The average thicknesses of macular, mGCC, and ppNFL in normal eyes were significantly different from those in GS or G eyes (p<0.001). The mGCC thickness correlated well with ppNFL thickness (correlation coefficients for N, GS, and G eyes are 0.397 [p=0.001], 0.822 [p<0.0001], and 0.865 [p<0.0001]). Areas under receiver operating characteristic curve of macular, mGCC, and ppNFL thickness are 0.940 (p<0.0001), 0.998 (p<0.0001), and 0.977 (p<0.0001), discriminating G from N eyes. There was no significant difference comparing the discriminating powers of NFL, GCC, and macular thickness.
Conclusions: The mGCC measurements provide another measurement of neural loss in glaucoma, and may serve as a promising parameter for ppNFL thickness in the clinical assessment of glaucoma. For glaucomatous eyes, mGCC and ppNFL thicknesses performed better discriminating abilities compared with macular thickness.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5301/ejo.5000131 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Retinal biomarkers for the risk of Alzheimer's disease and frontotemporal dementia.
Front Aging Neurosci
January 2025
Department of Neurology, West China Hospital of Sichuan University, Chengdu, China.
Purpose: Differentiating between Alzheimer's disease (AD) and frontotemporal dementia (FTD) can be challenging due to overlapping cognitive and behavioral manifestations. Evidence regarding non-invasive and early-stage biomarkers remains limited. Our aim was to identify retinal biomarkers for the risk of AD and FTD in populations without dementia and explore underlying brain structural mechanisms.
View Article and Find Full Text PDFEVALUATION OF MACULA GANGLION CELL ANALYSIS AND RETINAL NERVE FIBER LAYER THICKNESS IN PREPERIMETRIC GLAUCOMA, EARLY STAGE GLAUCOMA AND HEALTHY INDIVIDUALS.
Photodiagnosis Photodyn Ther
January 2025
Department of Ophthalmology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Turkey.
Purpose: In this study, it was planned to compare the macular ganglion cell analysis (GCA) and peripapillary retinal nerve fiber layer (pRNFL) of the patients with preperimetric glaucoma (PPG), early stage glaucoma (EG) and the control group.
Methods: This retrospective study included a total of 103 eyes: 38 from EG patients, 30 from PPG patients, and 35 from healthy individuals at Ankara Bilkent City Hospital Glaucoma Unit between January 2018 and September 2021. Eyes were categorized into control, PPG, and EG groups based on visual field (VF) classification.
Neuroprotective Effect of Melatonin Loaded in Human Serum Albumin Nanoparticles Applied Subconjunctivally in a Retinal Degeneration Animal Model.
Pharmaceutics
January 2025
Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA), CONICET and Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba 5000, Argentina.
Background/objectives: Neurodegenerative ocular diseases, such as age-related macular degeneration (AMD) and glaucoma, represent growing public health concerns. Oxidative stress plays a key role in their development, damaging retinal cells and accelerating disease progression. Melatonin (Mel) is a potent antioxidant with neuroprotective properties; however, it faces limitations such as low solubility.
View Article and Find Full Text PDFEffect of Different Treatments on Retinal Thickness Changes in Patients With Multiple Sclerosis: A Review.
CNS Neurosci Ther
January 2025
Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran.
Background: Multiple sclerosis (MS) is an autoimmune disorder affecting the central nervous system, with varying clinical manifestations such as optic neuritis, sensory disturbances, and brainstem syndromes. Disease progression is monitored through methods like MRI scans, disability scales, and optical coherence tomography (OCT), which can detect retinal thinning, even in the absence of optic neuritis. MS progression involves neurodegeneration, particularly trans-synaptic degeneration, which extends beyond the initial injury site.
View Article and Find Full Text PDFEffect of siponimod on retinal thickness, a marker of neurodegeneration, in participants with SPMS: Findings from the EXPAND OCT substudy.
Mult Scler Relat Disord
January 2025
Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland.
Background: People with MS show abnormal thinning of the retinal layers, which is associated with clinical disability and brain atrophy, and is a potential surrogate marker of neurodegeneration and treatment effects.
Objective: To evaluate the utility of retinal thickness as a surrogate marker of neurodegeneration and treatment effect in participants with secondary progressive MS (SPMS) from the optical coherence tomography (OCT) substudy of the EXPAND Phase 3 clinical trial (siponimod versus placebo).
Methods: In the OCT substudy population (n = 159), treatment effects on change in the average thickness of the retinal layer, peripapillary retinal nerve fiber layer (pRNFL), and combined macular ganglion cell and inner plexiform layers (GCIPL) were analyzed by high-definition spectral domain OCT at months 3, 12, and 24.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!